Supplementary Materials and Method from CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLCJeffrey H. Becker, Takeshi Shimamura(University of Illinois Chicago)UnknownMarch 31, 202310.1158/0008-5472.22421367.v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersThe impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies|Cancer Cell|2006|451Nitrite/nitrate oxide (NOx) and cytokine levels in patients with septic shock.|PubMed|1996|48